Filing Details
- Accession Number:
- 0001209191-22-002943
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-11 18:00:00
- Reporting Period:
- 2022-01-10
- Accepted Time:
- 2022-01-11 18:00:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 893949 | Mednax Inc. | MD | Services-Hospitals (8060) | 263667538 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1093125 | Md Roger Medel | 1301 Concord Terrace Sunrise FL 33323 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-10 | 59,893 | $26.44 | 779,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-01-11 | 40,107 | $26.58 | 739,450 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.04 to $26.75 for a weighted average sales price of $26.44. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.14 to $26.96 for a weighted average sales price of $26.58. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
